维普期刊资源整合服务平台（V6.5）

99篇 您的检索式：作者名="Nisman"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Prognostic role of serum cytokeratin 19 fragments in advanced non-small cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survival 显示文摘	Nisman B Biran H Heching N	2008	Br J Cancer2008，98，1：	1
2	An ELISA method for the detection and quantification of human heparanase显示文摘	Shafat I Zcharia E Nisman B Nadir Y Nakhoul F Vlodavsky I	2006	Biochem Biophys Res Commun2006，341，：	1
3	Serum thymidine kinase 1 activity in breast cancer显示文摘	Nisman B Allweis T Kaduri L	2010	Cancer Biomark2010，7，2：	1
4	Circulating tumor M2 pyruvate kinase and thymidine kinase 1 are potential predictors for disease re- cmTence in renal cell carcinoma after nephrectomy 显示文摘	Nisman B Yutkin V Nechushtan H	2010	Urology2010，76，2：	1
5	Evaluation of tissue polypeptide specific antigen,CYFRA21-1 and carcinoembryonic antigen in nonsmall cell lung carcinoma;does the combined use of cytokeratin markers give any additional information显示文摘	Nisman B Lafair J Heching N	2008	Gancer2008，1582，：	1
6	An ELISA method for the detection and quanlificatJon of human heparanase显示文摘	Shafat I Zcharia E Nisman B	2006	Bio chem Biophys Res Commun2006，341，4：	1
7	The diagnostic and prognostic value of ProGRP in lung cancer 显示文摘	Nisman B Biran H Ramu N	2009	Anticancer Res2009，29，11：	1
8	Serum thymidine kinase 1 activity in breast cancer显示文摘	Benjamin Nisman Tanir Allweis Luna Kaduri Bella Maly Simon Gronowitz Tamar Hamburger Tamar Peretz	2010	Cancer Biomarkers2010，，2：	1
9	Circulating tumor M2 pyruvate kinase and thymidine kinase 1 are potential predictors for disease re- currence in renal cell carcinoma after nephrectomy显示文摘	Nisman B Yutkin V Neehushtan H	2010	Urology2010，76，2：	1
10	Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome显示文摘	Abramov Y Barac V Nisman B		0，，：	1
11	查看详情显示文摘	Nisman B Barak V Shapiro A		0，，：	1
12	Prognostic role of serum cytokeratin 19 fragment in advanced non-small-cell lung cancer:association of marker changes after two chemotherapy cycles with different measures of clinical response and survival显示文摘	Nisman B Biran H Heching N	2008	British Journal of Cancer2008，98，1：	1
13	Prognostic role of serum cytokeratin 19 fragment in advanced non-small- cell lung cancer:association of nmrker changes after two chemotherapy cycles with different measures of clinical response and survival 显示文摘	Nisman B Biran H Heching N	2008	Brit J Can2008，98，1：	1
14	An ELISA method for the detection and quantification of human heparanase显示文摘	Shafat I Zcharia E Nisman B	2006	Biochem Biophys Res Commun2006，341，4：	1
15	An ELISA method for the detection and quantification of human heparanase 显示文摘	Shafat I Zcharia E Nisman B	2006	Biochem Biophys Res Commun2006，341，4：	1
16	Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer:association of marker changes after two chemotherapy cycles with different measures of clinical response and survival显示文摘	Nisman B Biran H Heching N	2008	Br J Cancer2008，98，1：	1
17	Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer:association of marker changes after two chemotherapy cycles with different measures of clinical response and survival显示文摘	Nisman B Biran H Heching N		0，，：	1
18	Serum thymidine kinaselac-tivity in breast cancer显示文摘	Nisman B Allweis T Kaduri L	2010	Cancer Biomark2010，7，2：	1
19	Evaluation of tissue polypeptide specific antigen,CYFRA21-1 and carcinoembryonic antigen in non-small cell lung carcinoma:does the combine use of cytokaratin markers give any additional information?显示文摘	Nisman B Lafair J Hecheng N	1998	Cancer1998，82，10：	1
20	Prognostic value of CYFRA21 - 1, TPS, and CEA in different histologic types of non small cell lung cancer显示文摘	Nisman B Amir G Lafair J	1999	Anti - cancer Res1999，19，4：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示